Sponsored
Inside the science of making medicines pure
Many clinically relevant molecules fall by the wayside because of the complex challenge of purifying them at industrial scale. That’s why understanding a molecule’s manufacturing liabilities early on is crucial, says global life science company Cytiva
Advertising